• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌的荧光成像

Fluorescence imaging of bladder cancer.

作者信息

D'Hallewin M A, Baert L, Vanherzeele H

机构信息

Department of Urology, K.U. Leuven, Belgium.

出版信息

Acta Urol Belg. 1994 Dec;62(4):49-52.

PMID:7793348
Abstract

Fluorescence tagging of tumors by sensitizing agents such as hematoporphyrin derivatives is an efficient method for diagnosing tumors but presents, even at low doses, a number of serious drawbacks for the patients. We demonstrate a fiberoptic instrument for the diagnosis of bladder cancer, based on a tripled frequency Nd YAG laser, without need for sensitizing agents, based on the autofluorescence of tissues. The contrast demarcation obtained for CIS and TCC respectively is 2.2 and 2.7, which is about 30% higher than what can be obtained after photosensitizing. The integration of the diagnostic method with a reliable therapeutic technique for tumor cell destruction, opens the way for cost-effective preventive care of high risk patients.

摘要

通过血卟啉衍生物等敏化剂对肿瘤进行荧光标记是一种有效的肿瘤诊断方法,但即便使用低剂量,对患者而言仍存在诸多严重缺点。我们展示了一种基于三倍频钕钇铝石榴石激光的用于诊断膀胱癌的光纤仪器,该仪器基于组织的自发荧光,无需敏化剂。原位癌(CIS)和移行细胞癌(TCC)分别获得的对比度分界为2.2和2.7,比光敏化后所能获得的对比度约高30%。将该诊断方法与可靠的肿瘤细胞破坏治疗技术相结合,为高危患者的经济高效预防护理开辟了道路。

相似文献

1
Fluorescence imaging of bladder cancer.膀胱癌的荧光成像
Acta Urol Belg. 1994 Dec;62(4):49-52.
2
In vivo fluorescence detection of human bladder carcinoma without sensitizing agents.无需致敏剂的人膀胱癌体内荧光检测
J Am Paraplegia Soc. 1994 Oct;17(4):161-4. doi: 10.1080/01952307.1994.11735929.
3
The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder.血卟啉衍生物(HpD)在膀胱移行细胞癌(TCC)定位及治疗中的应用。
Prog Clin Biol Res. 1984;170:795-804.
4
Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.己基氨基乙酰丙酸“蓝光”荧光膀胱镜检查在临床未确诊的阳性尿细胞学检查中的应用
BJU Int. 2009 May;103(10):1363-7. doi: 10.1111/j.1464-410X.2008.08238.x. Epub 2008 Dec 8.
5
[ALA fluorescent diagnosis of bladder cancer].[膀胱肿瘤的ALA荧光诊断]
Urologiia. 2000 Sep-Oct(5):48-50.
6
A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.一项关于六氨基乙酰丙酸荧光膀胱镜检查与白光膀胱镜检查用于检测膀胱癌患者浅表乳头状病变的多中心III期比较研究。
J Urol. 2007 Jul;178(1):62-7. doi: 10.1016/j.juro.2007.03.034. Epub 2007 May 11.
7
Fluorescence cystoscopy.荧光膀胱镜检查
Prog Clin Biol Res. 1984;162A:327-30.
8
[Fluorescence diagnosis of porphyrin-marked urothelial tumors. Status of experimental development].[卟啉标记的尿路上皮肿瘤的荧光诊断。实验进展状况]
Urologe A. 1989 Mar;28(2):59-64.
9
Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.光学相干断层扫描对膀胱基底膜区的可视化:肿瘤浸润无创评估的可行性
Urology. 2008 Sep;72(3):677-81. doi: 10.1016/j.urology.2008.02.062. Epub 2008 May 2.
10
5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.经尿道切除术中5-氨基乙酰丙酸诱导荧光膀胱镜检查可降低Ta/T1期膀胱癌的复发风险。
BJU Int. 2005 Oct;96(6):798-802. doi: 10.1111/j.1464-410X.2004.05715.x.

引用本文的文献

1
Development of a modular fluorescence overlay tissue imaging system for wide-field intraoperative surgical guidance.用于广视野术中手术导航的模块化荧光叠加组织成像系统的开发。
J Med Imaging (Bellingham). 2018 Apr;5(2):021220. doi: 10.1117/1.JMI.5.2.021220. Epub 2018 Mar 2.
2
Fiberoptic imaging for urologic surgery.
Curr Urol Rep. 2009 Jan;10(1):60-4. doi: 10.1007/s11934-009-0011-1.
3
Fluorescence spectroscopy of neoplastic and non-neoplastic tissues.肿瘤组织与非肿瘤组织的荧光光谱学
Neoplasia. 2000 Jan-Apr;2(1-2):89-117. doi: 10.1038/sj.neo.7900077.